Citadel Securities LLC has recently announced that it has increased stake in Bio-Key International Inc. (NASDAQ:BKYI) by 117.86%. After grabbing 21331.0 shares, the institutional investor is now in possession of 11540.0 shares of the Industrials Company. The new investment brought the stake of investor firm to 0.23% having worth around $4266.0. Moreover, Renaissance Technologies LLC increased its share by 10900.0 to have a control over 10900.0 shares. And Wells Fargo Bank, NA raised its holdings to 1.0 shares by acquiring 61.0 shares or 0.00% of the stake.
Bio-Key International Inc. (BKYI) concluded trading on 11/30/23 at a closing price of $0.22, with 12.15 million shares of worth about $2.67 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -72.44% during that period and on Thursday the price saw a gain of about 26.62%. Currently the company’s common shares owned by public are about 13.73M shares, out of which, 10.52M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 1 analysts are covering the BKYI stock and their offered price forecasts bring an average price target of $1.00. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $1.00 and could fall to a lowest price of $1.00. The stock’s current price level is 78.0% above of average price target set by the analysts, while a rise to estimated low would result in gain of 78.0% for the stock. However, touching the estimated high of $1.00 would mean a gain of 78.0% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 39 times over the past 12 months. They bought 654,612 shares in 39 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Vanguard Extended Market Index Fu, Fidelity Extended Market Index Fu, and Fidelity Series Total Market Inde are the top 3 mutual funds which are holding stakes in Bio-Key International Inc. Vanguard Extended Market Index Fu is currently holding 0.11 million shares of worth totaling $21889.0. The company recently came buying 0.0 shares which brought its stake up to 1.16% of the company’s outstanding shares. Fidelity Series Total Market Inde, after buying 11210.0 shares, have now control over 0.12% of the stake in the company. It holds 0.0 shares of worth $2242.0.
Bio-Key International Inc. (NASDAQ: BKYI) started trading at $0.177, above $0.01 from concluding price of the previous day. However, the stock later moved at a day high price of 0.2460, or with a gain of 26.62%. Stock saw a price change of 42.38% in past 5 days and over the past one month there was a price change of 7.61%. Year-to-date (YTD), BKYI shares are showing a performance of -63.25% which decreased to -78.31% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.14 but also hit the highest price of $1.03 during that period. The average intraday trading volume for Bio-Key International Inc. shares is 1.10 million. The stock is currently trading 21.19% above its 20-day simple moving average (SMA20), while that difference is down -31.94% for SMA50 and it goes to -64.84% lower than SMA200.
Citadel Securities LLC acquired 21331.0 shares of Bio-Key International Inc. having value of about $4266.0. Data submitted at the U.S SEC by Citadel Securities LLC revealed that the firm now holds 11540.0 shares in the company valued at close to $2538.8, or have control over 117.86% stake in the company. Bio-Key International Inc. (NASDAQ: BKYI) currently have 13.73M outstanding shares and institutions hold larger chunk of about 1.94% of that. Holding of mutual funds in the company is about 16.29% while other institutional holders and individual stake holders have control over 2.04% and 0.79% of the stake respectively.
The stock has a current market capitalization of $2.95M and its 3Y-monthly beta is at 0.95. It has posted earnings per share of -$0.88 in the same period. It has Quick Ratio of 0.59 while making debt-to-equity ratio of 0.83. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BKYI, volatility over the week remained 23.38% while standing at 15.16% over the month.
Analysts are in expectations that Bio-Key International Inc. (BKYI) stock would likely to be making an EPS of $0 in the current quarter, while forecast for next quarter EPS is $0 and it is $0 for next year. For the current quarter EPS, analysts have given the company a lowest target $0 which is $0 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.29 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 76.98% while it is estimated to increase by 120.69% in next year.
Analysts at 1 brokerage firms have issued recommendations for the Bio-Key International Inc. (BKYI)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on March 26, 2021 offering a Buy rating for the stock and assigned a target price of $6 to it.
